Patent · US Expired

Non-depleting anti-CD4 monoclonal antibodies and tolerance induction

US6056956A · kind A · utility

26Cited by
3References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 6, 1995
Grant dateMay 2, 2000
Priority date
Expiry dateJun 6, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/505
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Tolerance to an antigen is induced in a subject by administering a non-depleting CD4 monoclonal antibody and a non-depleting CD8 monoclonal antibody. Tolerance to the antigen can be induced under cover of these antibodies. A depleting CD4 monoclonal antibody and/or a depleting CD8 monoclonal antibody may be administered prior to the non-depleting antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.